-+ 0.00%
-+ 0.00%
-+ 0.00%

CVS will pay almost $38M to settle charges of over-dispensing insulin pens

Barchart·12/03/2025 14:30:15
Listen to the news
The retailer admits to receiving payments for pen refills that were ineligible for reimbursement